Does “man flu” exist? How effective is the flu vaccine? And do pets keep you healthy? These are just some of the questions scientists from the London School of Hygiene & Tropical Medicine want to explore as they launch a nationwide flu survey.
[More]
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
[More]
Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.
[More]
UK funding for infectious diseases research is neglecting some of the diseases that result in the highest rates of death and disability, according to an Article published Online First in The Lancet Infectious Diseases.
[More]
Assassin bugs, so named because these insects lie in ambush for prey that they attack with speed and precision, are found all over the world. Nearly 140 species of these bugs are blood-sucking; because they can bite humans around the mouth, they are also called kissing bugs. All kissing bugs can spread Chagas disease, a neglected tropical disease that imposes an economic burden on society.
[More]
At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria (ICTMM) and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation (FIOCRUZ) and the Drugs for Neglected Diseases initiative (DNDi) Latin America, uniting the three actors into a strategic partnership to collaborate on research and development (R&D) for new therapies and diagnostics for neglected diseases.
[More]
A potentially dangerous new malaria-transmitting mosquito has been discovered in Kenya by scientists from the London School of Hygiene & Tropical Medicine. This species, which has never been implicated in the transmission of malaria before, poses a threat because it bites humans at times when they are not protected by current malaria control techniques.
[More]
A pair of provocative studies in the July 2012 issue of The American Journal of Tropical Medicine and Hygiene (AJTMH) provides a window into the intense ground war now underway against malaria.
[More]
Astellas Pharma Inc. and the Drugs for Neglected Diseases initiative (DNDi) announced an agreement today to collaborate on drug discovery research for leishmaniasis, Chagas disease, and sleeping sickness - three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide.
[More]
"Chagas disease, a parasitic infection spread to humans by insects, is not the new HIV/AIDS of the Americas, according to infectious disease experts who called the comparison," made in an editorial published in PLoS Neglected Tropical Diseases last week, "'unrealistic' and 'unfortunate,'" ABC News' "Medical Unit" blog reports.
[More]
"Chagas disease -- a parasitic infection transmitted through an insect commonly known as the 'kissing bug' -- is one of the most common infections among pregnant women in the Western Hemisphere," Peter Hotez, president of the Sabin Vaccine Institute and director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, writes in the Huffington Post's "Global Motherhood" blog.
[More]
AstraZeneca and the Drugs for Neglected Diseases initiative (DNDi) today announce an agreement to collaborate on drug-compound screening for leishmaniasis, Chagas disease, and sleeping sickness, three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide.
[More]
"As we have seen in our work in Haiti and around the world, shoes are a first level of defense when it comes to good health, and are a great complement to the Neglected Tropical Disease (NTD) Control program IMA World Health implements in Haiti," Rick Santos, president and CEO of IMA World Health, writes in the Huffington Post Blog, commemorating One Day Without Shoes, observed on Tuesday.
[More]
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Stephanie Ogden -- a water, sanitation and hygiene (WASH) and neglected tropical disease (NTD) consultant with Emory's Center for Global Safe Water, Children Without Worms, and the International Trachoma Initiative -- writes about a partnership among these organizations.
[More]
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog highlights "the first-ever international podoconiosis initiative, Footwork," launched on March 15.
[More]
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
[More]
The Drugs for Neglected Diseases initiative (DNDi) has commenced a Phase I clinical trial in healthy adults in Paris, France, to determine the safety and tolerability of a promising oral drug candidate Oxaborole SCYX-7158, to treat human African trypanosomiasis (HAT, or sleeping sickness) for stage 1 and stage 2 of the disease.
[More]
A study published in PLoS Neglected Tropical Disease on Tuesday examines the relationship between political conflict in the Middle East and North Africa (MENA) region and "the spread or re-emergence of a variety of tropical diseases -- some previously eliminated or controlled -- affecting an estimated 65 million people" in the region, VOA News reports.
[More]
In this AlertNet opinion piece, Simon Bush, director of neglected tropical diseases (NTDs) at Sightsavers, an international NGO helping people with visual impairments in developing countries, examines efforts to rid Africa of onchocerciasis -- a blinding NTD.
[More]
The Neglected Tropical Disease Control Program (NTD Control Program), funded by USAID and managed by Research Triangle Institute International (RTI International), has released an updated version of its NTD Funding Gap Analysis Tool (NTD-FGAT), which "helps users accurately estimate the costs and funding gaps of public health programs" and "is intended as a supplementary instrument to improve resource and strategic planning in an already existing national NTD plan," according to the Global Network for NTDs' "End the Neglect" blog.
[More]